Literature DB >> 21441122

Sclerostin: just one more player in renal bone disease?

Tilman B Drüeke, Marie-Hélène Lafage-Proust.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21441122     DOI： 10.2215/CJN.01370211

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  11 in total

1.  The relation between renal function and serum sclerostin in adult patients with CKD.

Authors:  Solenne Pelletier; Laurence Dubourg; Marie-Christine Carlier; Aoumeur Hadj-Aissa; Denis Fouque
Journal:  Clin J Am Soc Nephrol       Date:  2013-02-21       Impact factor: 8.237

2.  Sclerostin as a new key factor in vascular calcification in chronic kidney disease stages 3 and 4.

Authors:  Wei Lv; Lina Guan; Yan Zhang; Shengqiang Yu; Bofeng Cao; Yongqiang Ji
Journal:  Int Urol Nephrol       Date:  2016-07-27       Impact factor: 2.370

Review 3.  Sclerostin, cardiovascular disease and mortality: a systematic review and meta-analysis.

Authors:  Mehmet Kanbay; Yalcin Solak; Dimitrie Siriopol; Gamze Aslan; Baris Afsar; Dilek Yazici; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2016-08-06       Impact factor: 2.370

4.  Relative influence of heritability, environment and genetics on serum sclerostin.

Authors:  A L Kuipers; Y Zhang; S Yu; C M Kammerer; C S Nestlerode; Y Chu; C H Bunker; A L Patrick; V W Wheeler; I Miljkovic; J M Zmuda
Journal:  Osteoporos Int       Date:  2013-10-18       Impact factor: 4.507

5.  Sclerostin as a new key player in arteriovenous fistula calcification.

Authors:  M Balcı; A Kırkpantur; A Turkvatan; S Mandıroglu; E Ozturk; B Afsar
Journal:  Herz       Date:  2013-10-19       Impact factor: 1.443

6.  Markers of bone metabolism are affected by renal function and growth hormone therapy in children with chronic kidney disease.

Authors:  Anke Doyon; Dagmar-Christiane Fischer; Aysun Karabay Bayazit; Nur Canpolat; Ali Duzova; Betül Sözeri; Justine Bacchetta; Ayse Balat; Anja Büscher; Cengiz Candan; Nilgun Cakar; Osman Donmez; Jiri Dusek; Martina Heckel; Günter Klaus; Sevgi Mir; Gül Özcelik; Lale Sever; Rukshana Shroff; Enrico Vidal; Elke Wühl; Matthias Gondan; Anette Melk; Uwe Querfeld; Dieter Haffner; Franz Schaefer
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

Review 7.  Vascular calcification and renal bone disorders.

Authors:  Kuo-Cheng Lu; Chia-Chao Wu; Jen-Fen Yen; Wen-Chih Liu
Journal:  ScientificWorldJournal       Date:  2014-07-17

8.  Relationship between Fetuin A, Vascular Calcification and Fracture Risk in Dialysis Patients.

Authors:  Hung Yuan Chen; Yen Ling Chiu; Shih Ping Hsu; Mei Fen Pai; Ju Yeh Yang; Yu Sen Peng
Journal:  PLoS One       Date:  2016-07-11       Impact factor: 3.240

9.  Hemodiafiltration Is Associated With Reduced Inflammation and Increased Bone Formation Compared With Conventional Hemodialysis in Children: The HDF, Hearts and Heights (3H) Study.

Authors:  Dagmar-Christiane Fischer; Colette Smith; Francesca De Zan; Justine Bacchetta; Sevcan A Bakkaloglu; Ayse Agbas; Ali Anarat; Bilal Aoun; Varvara Askiti; Karolis Azukaitis; Aysun Bayazit; Ipek Kaplan Bulut; Nur Canpolat; Dagmara Borzych-Dużałka; Ali Duzova; Sandra Habbig; Saoussen Krid; Christoph Licht; Mieczyslaw Litwin; Lukasz Obrycki; Fabio Paglialonga; Anja Rahn; Bruno Ranchin; Charlotte Samaille; Mohan Shenoy; Manish D Sinha; Brankica Spasojevic; Constantinos J Stefanidis; Enrico Vidal; Alev Yilmaz; Michel Fischbach; Franz Schaefer; Claus Peter Schmitt; Rukshana Shroff
Journal:  Kidney Int Rep       Date:  2021-07-06

10.  Independent association between serum sclerostin levels and carotid artery atherosclerosis in prevalent haemodialysis patients.

Authors:  Alper Kirkpantur; Mustafa Balci; Aysel Turkvatan; Baris Afsar
Journal:  Clin Kidney J       Date:  2015-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.